Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells

Neurosci Lett. 2002 Jan 11;317(2):61-4. doi: 10.1016/s0304-3940(01)02449-1.

Abstract

Up-regulation of neuronal cyclooxygenase-2 (COX-2) and the elevation in prostaglandin E(2) (PGE(2)) have been reported to occur after cerebral ischemic insult. To evaluate whether the COX-2 reaction product PGE(2) is directly related to induction of apoptosis in neuronal cells, the effect of PGE(2) on cell viability was examined in rat cortical cells. PGE(2) induced apoptosis in a dose-dependent manner (5-25 microM) 48 h after addition to the cells, which was characterized by cell shrinkage, nuclear condensation or fragmentation, and internucleosomal DNA fragmentation. Neither 17-phenyl trinor-prostaglandin E(2) (an EP1 agonist) or sulprostone (an EP3 agonist) induced cell death, whereas butaprost (an EP2 agonist) induced apoptotic cell death. In addition, PGE(2) activated caspase-3 in a time-dependent manner until 24 h after treatment. The apoptosis induced by PGE(2) was prevented by a caspase-3 inhibitor in a dose-dependent manner. In contrast, dibutyryl cyclic adenosine monophosphate also induced apoptotic cell death in a dose-dependent manner (20-100 microM). These results suggest that PGE(2), acting via an EP2-like receptor, induces apoptosis in neurons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylyl Cyclases / metabolism
  • Alprostadil / analogs & derivatives*
  • Alprostadil / pharmacology
  • Animals
  • Apoptosis / drug effects*
  • Brain Ischemia / metabolism
  • Brain Ischemia / pathology
  • Bucladesine / pharmacology
  • Caspase 3
  • Caspase Inhibitors
  • Caspases / physiology*
  • Cells, Cultured / drug effects
  • Cells, Cultured / metabolism
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / enzymology
  • Cerebral Cortex / pathology
  • Cyclic AMP / physiology
  • Cyclooxygenase 2
  • Cysteine Proteinase Inhibitors / pharmacology
  • Dinoprostone / analogs & derivatives*
  • Dinoprostone / pharmacology*
  • Dose-Response Relationship, Drug
  • Enzyme Activation / drug effects
  • Isoenzymes / physiology
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Nerve Tissue Proteins / physiology*
  • Prostaglandin Antagonists / pharmacology
  • Prostaglandin-Endoperoxide Synthases / physiology
  • Rats
  • Receptors, Prostaglandin E / antagonists & inhibitors
  • Receptors, Prostaglandin E / physiology
  • Receptors, Prostaglandin E, EP1 Subtype
  • Receptors, Prostaglandin E, EP2 Subtype
  • Receptors, Prostaglandin E, EP3 Subtype
  • Second Messenger Systems / physiology
  • Signal Transduction / drug effects*
  • Signal Transduction / physiology

Substances

  • 17-phenyltrinorprostaglandin E2
  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Isoenzymes
  • Nerve Tissue Proteins
  • Prostaglandin Antagonists
  • Ptger1 protein, rat
  • Ptger2 protein, rat
  • Ptger3 protein, rat
  • Receptors, Prostaglandin E
  • Receptors, Prostaglandin E, EP1 Subtype
  • Receptors, Prostaglandin E, EP2 Subtype
  • Receptors, Prostaglandin E, EP3 Subtype
  • sulprostone
  • Bucladesine
  • Cyclic AMP
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • Casp3 protein, rat
  • Caspase 3
  • Caspases
  • Adenylyl Cyclases
  • Alprostadil
  • butaprost
  • Dinoprostone